A Trial in Healthy Adult Participants and Adults With Autoimmune Disease to Test How HBM7020 is Tolerated and Absorbed in the Body
Clinical trial NCT07649265 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07649265
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-09-15
- Primary completion
- 2028-11-20
- Enrollment
- 63
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.